Logo-apb
Adv Pharm Bull. 2017;7(3): 359-365. doi: 10.15171/apb.2017.043
PMID: 29071217        PMCID: PMC5651056

Research Article

Modafinil Improves Catalepsy in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease; Possible Involvement of Dopaminergic Neurotransmission

Reza Vajdi-Hokmabad 1, Mojtaba Ziaee 2, Saeed Sadigh-Eteghad 3, Siamak Sandoghchian Shotorbani 4, Javad Mahmoudi 3 *

Cited by CrossRef: 4


1- Brandão W, Andersen M, Palermo-Neto J, Peron J, Zager A. Therapeutic treatment with Modafinil decreases the severity of experimental autoimmune encephalomyelitis in mice. International Immunopharmacology. 2019;75:105809 [Crossref]
2- Yousefi-Manesh H, Rashidian A, Hemmati S, Shirooie S, Sadeghi M, Zarei N, Dehpour A. Therapeutic effects of modafinil in ischemic stroke; possible role of NF-κB downregulation. Immunopharmacology and Immunotoxicology. 2019;41(5):558 [Crossref]
3- Kumar S, Kumar P. The Beneficial Effect of Rice Bran Extract Against Rotenone-Induced Experimental Parkinson’s Disease in Rats. CMP. 2021;14(3):428 [Crossref]
4- Turkez H, Altay O, Yildirim S, Li X, Yang H, Bayram C, Bolat I, Oner S, OzdemirTozlu O, Arslan M, Arif M, Yulug B, Hanoglu L, Cankaya S, Lam S, Velioglu H, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Hacimuftuoglu A, Shoaie S, Zhang C, Nielsen J, Borén J, Uhlén M, Mardinoglu A. RETRACTED: Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases. Life Sciences. 2023;314:121325 [Crossref]